Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bay

Showing results (121-130 of 253) with videos related to

Pageof 26
Sort By:
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 22, 2011
Post-translational modifications of the extracellular matrix are key events in cancer progression: opportunities for biochemical marker developmentD J Leeming, A C Bay-Jensen, E Vassiliadis, et al.
BMC Research Notes|October 15, 2011
Identification of the calcitonin receptor in osteoarthritic chondrocytesToni Segovia-Silvestre, Caroline Bonnefond, Bodil C Sondergaard, et al.
Osteoarthritis and Cartilage|November 26, 2009
MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation--divergence in pathways leading to aggrecanase and MMP-mediated articular cartilage degradationB-C Sondergaard, N Schultz, S H Madsen, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|November 21, 2018
Citrullinated vimentin and biglycan protein fingerprints as candidate serological biomarkers for disease activity in systemic sclerosis: a pilot studyAnne Sofie Siebuhr, Pernille Juhl, Anne-C Bay-Jensen, et al.
The Laryngoscope|January 28, 2025
Inconsistent Associations of Modified Frailty Index-5 With Adverse Head and Neck Reconstruction OutcomesDoruk Orgun, Caroline C Bay, Kristine M Carbullido, et al.
Osteoarthritis and Cartilage Open|June 21, 2023
Pathological tissue formation and degradation biomarkers correlate with patient reported pain outcomes: an explorative studyAnne C Bay-Jensen, Mukundan Attur, Jonathan Samuels, et al.
Annals of the Rheumatic Diseases|February 14, 2009
Circulating nitrated N-telopeptide of type III collagen (IIINys) as a biochemical marker of oxidative-related synovial tissue metabolism in rheumatoid arthritisN Charni-Ben Tabassi, P Richardot, L Toh, et al.
Osteoarthritis and Cartilage|May 27, 2009
Nitrated type III collagen as a biological marker of nitric oxide-mediated synovial tissue metabolism in osteoarthritisP Richardot, N Charni-Ben Tabassi, L Toh, et al.
Alimentary Pharmacology & Therapeutics|May 9, 2017
Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's diseaseW T van Haaften, J H Mortensen, M A Karsdal, et al.
Rheumatology (Oxford, England)|August 10, 2022
Serum biomarkers in prednisolone-treated hand osteoarthritis patientsLotte A van de Stadt, Féline P B Kroon, Christian F Thudium, et al.
Pageof 26

Showing results (121-130 of 253) with videos related to

Sort By:
Pageof 26
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 22, 2011
Post-translational modifications of the extracellular matrix are key events in cancer progression: opportunities for biochemical marker developmentD J Leeming, A C Bay-Jensen, E Vassiliadis, et al.
BMC Research Notes|October 15, 2011
Identification of the calcitonin receptor in osteoarthritic chondrocytesToni Segovia-Silvestre, Caroline Bonnefond, Bodil C Sondergaard, et al.
Osteoarthritis and Cartilage|November 26, 2009
MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation--divergence in pathways leading to aggrecanase and MMP-mediated articular cartilage degradationB-C Sondergaard, N Schultz, S H Madsen, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|November 21, 2018
Citrullinated vimentin and biglycan protein fingerprints as candidate serological biomarkers for disease activity in systemic sclerosis: a pilot studyAnne Sofie Siebuhr, Pernille Juhl, Anne-C Bay-Jensen, et al.
The Laryngoscope|January 28, 2025
Inconsistent Associations of Modified Frailty Index-5 With Adverse Head and Neck Reconstruction OutcomesDoruk Orgun, Caroline C Bay, Kristine M Carbullido, et al.
Osteoarthritis and Cartilage Open|June 21, 2023
Pathological tissue formation and degradation biomarkers correlate with patient reported pain outcomes: an explorative studyAnne C Bay-Jensen, Mukundan Attur, Jonathan Samuels, et al.
Annals of the Rheumatic Diseases|February 14, 2009
Circulating nitrated N-telopeptide of type III collagen (IIINys) as a biochemical marker of oxidative-related synovial tissue metabolism in rheumatoid arthritisN Charni-Ben Tabassi, P Richardot, L Toh, et al.
Osteoarthritis and Cartilage|May 27, 2009
Nitrated type III collagen as a biological marker of nitric oxide-mediated synovial tissue metabolism in osteoarthritisP Richardot, N Charni-Ben Tabassi, L Toh, et al.
Alimentary Pharmacology & Therapeutics|May 9, 2017
Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's diseaseW T van Haaften, J H Mortensen, M A Karsdal, et al.
Rheumatology (Oxford, England)|August 10, 2022
Serum biomarkers in prednisolone-treated hand osteoarthritis patientsLotte A van de Stadt, Féline P B Kroon, Christian F Thudium, et al.
Pageof 26